Honest, research-backed journalism on ivermectin, fenbendazole, HCQ, and your right to medical sovereignty. Updated daily.
In parts of Central Africa, mass ivermectin treatment can trigger severe reactions in people with heavy Loa loa infection—here's the evidence and how screening solved it.
Treating entire communities, not just the visibly sick, has eliminated river blindness and filariasis in whole regions—here is the evidence and its limits.
Azithromycin's unusual chemistry allows short courses to work, but that same chemistry raises real questions about resistance and cardiac safety worth understanding.
Lab studies showed ivermectin stopping viruses in a dish, but the doses needed never matched what a human body can safely achieve.
A close look at the actual clinical trial and cohort evidence behind hydroxychloroquine's use in lupus and rheumatoid arthritis, and where it falls short.
Doxycycline is a reliable, well-studied antibiotic, but two side effects—sunburn-like skin reactions and pill-induced esophageal irritation—are predictable enough to prepare for in advance.
Ivermectin paralyzes parasites by locking open a chloride channel mammals don't have, and a second safeguard keeps it out of the human brain.
Laboratory and animal studies have found intriguing anticancer effects of ivermectin, but no human trial has proven it treats cancer. Here is the evidence, honestly weighed.
Fever, gut trouble, or skin lesions weeks after travel abroad may signal a parasitic infection. Here's what deserves a doctor's attention and why.